Company created to progress experimental Alzheimer's disease therapy
Company created to progress experimental Alzheimer's disease therapy The group has previously shown that molecules that act on RAR-alpha can affect multiple parts of the Alzheimer's disease pathway and therefore have the potential to produce an effective therapy that would otherwise need several points of intervention ...